"In vitro and in silico perspectives to explain anticancer activity of a ..."

Srinivasulu Cheemanapalli et al. (2023)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2022.106349

access: closed

type: Journal Article

metadata version: 2025-03-03

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/CheemanapalliPM23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/CheemanapalliPM23
Srinivasulu Cheemanapalli, Chandrasekaran Palaniappan, Yeshwanth Mahesh, Yuvaraj Iyyappan, Suresh Yarrappagaari, Kanagaraj Sekar:
In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. Comput. Biol. Medicine 152: 106349 (2023)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.